title: Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study.
authors.affiliation: Department of Pulmonary Diseases, St. Antonius Hospital Nieuwegein, Nieuwegein, the Netherlands. kwmaas@hotmail.com
authors.forename: Klaartje W
authors.initials: KW
authors.lastname: Maas
authors.forename: Sherif Y
authors.initials: SY
authors.lastname: El Sharouni
authors.forename: Erik C J
authors.initials: EC
authors.lastname: Phernambucq
authors.forename: Jos A
authors.initials: JA
authors.lastname: Stigt
authors.forename: Harry J M
authors.initials: HJ
authors.lastname: Groen
authors.forename: Gerarda J M
authors.initials: GJ
authors.lastname: Herder
authors.forename: Ben E E M
authors.initials: BE
authors.lastname: Van Den Borne
authors.forename: Suresh
authors.initials: S
authors.lastname: Senan
authors.forename: Marinus A
authors.initials: MA
authors.lastname: Paul
authors.forename: Egbert F
authors.initials: EF
authors.lastname: Smit
authors.forename: Franz M N H
authors.initials: FM
authors.lastname: Schramel
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D000077143:Docetaxel; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011878:Radiotherapy / Q000009:adverse effects; D015996:Survival Rate; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D002945:Cisplatin